In the News July 21, 2022

Law360 | 3 Firms Guide Biopharma Co. ZyVersa’s $109M SPAC Merger

Alston & Bird is noted for representing Larkspur Health Acquisition Corp. in a planned $109 million merger with ZyVersa Therapeutics Inc.
Media Contact
Alex Wolfe
Communications Director

This website uses cookies to improve functionality and performance. For more information, see our Privacy Statement. Additional details for California consumers can be found here.